Predicting PET‐Based Amyloid and Tau Pathology Stages With Plasma Biomarkers in Alzheimer's disease

Han‐Kyeol Kim, Jae Hoon Lee, Joong‐Hyun Chun, Jeong‐Ha Lee, Tim West, Kristopher M. Kirmess, Philip B. Verghese, Joel B. Braunstein, Daniel Connell, Young Hoon Ryu, Chul Hyoung Lyoo, Hanna Cho · 2025

Read Predicting PET‐Based Amyloid and Tau Pathology Stages With Plasma Biomarkers in Alzheimer's disease by Han‐Kyeol Kim, Jae Hoon Lee, Joong‐Hyun Chun, Jeong‐Ha Lee, Tim West, Kristopher M. Kirmess, Philip B. Verghese, Joel B. Braunstein, Daniel Connell, Young Hoon Ryu, Chul Hyoung Lyoo, Hanna Cho (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11716818.txt.

Description

Han-Kyeol Kim and eleven co-authors published a study in 2025 on whether blood tests can reveal the stage of Alzheimer's pathology in the brain. Scans can stage amyloid spread and tau spread, but they are costly and scarce. The team compared three blood measures against scan-based stages in the same patients.

Two hundred thirty-two people had two kinds of scan plus blood tests. A ratio built from two forms of one tau protein matched both amyloid and tau stages best. It predicted early and late stages with strong accuracy. The plain tau measure tracked tau stage well but amyloid stage less so. A blood ratio might let clinics stage disease without a scanner.

Catalog record

CREATORHan‐Kyeol Kim, Jae Hoon Lee, Joong‐Hyun Chun, Jeong‐Ha Lee, Tim West, Kristopher M. Kirmess, Philip B. Verghese, Joel B. Braunstein, Daniel Connell, Young Hoon Ryu, Chul Hyoung Lyoo, Hanna Cho
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE2 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11716818

Browse the full library · About the Tower of Babel